Caesarstone Announces Annual General Meeting of Shareholders
Bitget2026/10/21 20:19- Caesarstone will hold its annual shareholder meeting on November 25, 2026, at its offices in Kibbutz Sdot-Yam, Israel.
- Shareholders will vote to increase shares reserved for incentive stock options under the 2020 Share Incentive Plan from 3,500,000 to 5,500,000.
- A proposed three-year compensation policy would allow special bonuses in equity and restrict the 10% dilution cap to officers and directors.
- Board election proposals cover seven nominees, with equity grants of 3,750 options per director subject to shareholder approval.
- Other proposals cover Eran Cohen's employment as ROW Sales Director at NIS 36,000 monthly base salary and the independent auditors' reappointment.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
WTI crude oil futures prices fall by more than 1%
Yen appreciation and global bond slump lead Japan GPIF to first loss in six quarters, with almost no asset allocation adjustment
According to the latest quarterly report from Japan’s Government Pension Investment Fund (GPIF), its asset allocation remained almost unchanged from its model portfolio for the three months ending in late September. However, the fund recorded a 1.7% quarterly loss during this period—the first loss in six quarters—due to a global slump in bond prices and the appreciation of the yen.
GlaxoSmithKline endorses: anti-inflammatory biotech company Rezera (RZRA.US) plans to raise $200 millions through IPO, with a valuation of $254 millions
Rezera plans to raise $200 million in its IPO on Nasdaq, with an offering price between $11 and $13. GSK intends to subscribe for up to $25 million. The mid-point valuation is $254 million, and the company focuses on oral NLRP3 inhibitors.
BUZZ-3M India shares fall to 19-month low due to quarterly profit decline
Crypto prices
More
